Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01351727 · ClinicalTrials.gov registry record

Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors

A clinical trial of Epileptic Seizures, sponsored by University of Arizona.

Completed
Registry status
97
Enrollment target
1
Study location

NCT01351727 is a study of Epileptic Seizures that has completed, run by University of Arizona. The registered enrollment target is 97 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01351727, a study of Epileptic Seizures, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
97 participants
Enrollment target
1
Study location

Study Summary

The purpose of this proposed research is to identify individuals in southeastern Arizona aged 65 years and older who have new onset seizures (or newly diagnosed epilepsy) and monitor them for at least two years. In doing so the investigators will be able to describe the public health burden of this condition and to identify factors that predict clinical outcomes and health care needs in this population, using quantitative, administrative, and qualitative data. The aims of this proposed research are 1) to determine the two-year incidence of newly diagnosed epilepsy in the target population, 2) describe health care resource utilization of the target population using Medicare data, 3) validate the use of Medicare beneficiary data to estimate incidence of epilepsy, and 4) describe the burden of this condition in different ethnic groups.

Conditions Studied

Study Locations (1)

Arizona

  • Pima, Cochise, Santa Cruz Counties - Tucson

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2011-01
Est. Completion 2014-09

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT01351727

The ClinicalTrials.gov registry entry for NCT01351727 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epileptic Seizures appearing as the primary indexed condition, and to 0 interventions.

NCT01351727 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT01351727 about?

NCT01351727 is a clinical study titled "Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors". The purpose of this proposed research is to identify individuals in southeastern Arizona aged 65 years and older who have new onset seizures (or newly diagnosed epilepsy) and monitor them for at least two years. In doing so the investigators will be able to describe the public health burden of this ...

What is the current status of trial NCT01351727?

This trial is currently completed. The enrollment target is 97 participants. The study started on 2011-01. Estimated completion is 2014-09.

What conditions does trial NCT01351727 study?

This clinical trial studies the following conditions: Epileptic Seizures.

Who is sponsoring clinical trial NCT01351727?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01351727 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.